blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2984185

EP2984185 - METHODS AND COMPOSITIONS FOR TREATING CANCER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.04.2020
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  10.05.2019
FormerGrant of patent is intended
Status updated on  13.01.2019
FormerExamination is in progress
Status updated on  16.02.2018
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[2016/07]
Inventor(s)01 / CHANG, Ken C. N.
126 East Lincoln Avenue
Rahway New Jersey 07065-0907 / US
02 / GALUSKA, Stefan
76 Mali Drive
North Plainfield New Jersey 07062 / US
03 / MARTON, Matthew, J.
126 East Lincoln Avenue
Rahway New Jersey 07065-0907 / US
 [2016/07]
Representative(s)Jaap, David Robert, et al
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2016/07]Jaap, David Robert, et al
Merck & Co., Inc.
Patent Department
Hertford Road
Hoddesdon, Herts EN11 9BU / GB
Application number, filing date14783222.403.04.2014
[2016/07]
WO2014US32745
Priority number, dateUS201361809612P08.04.2013         Original published format: US 201361809612 P
[2016/07]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2014168801
Date:16.10.2014
Language:EN
[2014/42]
Type: A2 Application without search report 
No.:EP2984185
Date:17.02.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 16.10.2014 takes the place of the publication of the European patent application.
[2016/07]
Type: B1 Patent specification 
No.:EP2984185
Date:12.06.2019
Language:EN
[2019/24]
Search report(s)International search report - published on:US08.10.2015
(Supplementary) European search report - dispatched on:EP23.12.2016
ClassificationIPC:C12Q1/68
[2016/07]
CPC:
C12Q1/6886 (EP,US); A61K31/416 (EP,US); C12Q1/6858 (EP,US);
C12Q2600/106 (EP,US); C12Q2600/156 (EP,US)
C-Set:
C12Q1/6858, C12Q2525/204, C12Q2535/125, C12Q2537/143 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/20]
Former [2016/07]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA08.04.2016
ME08.04.2016
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON KREBS[2016/07]
English:METHODS AND COMPOSITIONS FOR TREATING CANCER[2016/07]
French:PROCÉDÉS ET COMPOSITIONS POUR LE TRAITEMENT DU CANCER[2016/07]
Entry into regional phase09.11.2015National basic fee paid 
09.11.2015Search fee paid 
Examination procedure08.04.2016Examination requested  [2016/20]
13.07.2017Amendment by applicant (claims and/or description)
19.02.2018Despatch of a communication from the examining division (Time limit: M04)
26.06.2018Reply to a communication from the examining division
14.01.2019Communication of intention to grant the patent
03.05.2019Fee for grant paid
03.05.2019Fee for publishing/printing paid
03.05.2019Receipt of the translation of the claim(s)
Opposition(s)13.03.2020No opposition filed within time limit [2020/21]
Fees paidRenewal fee
30.03.2016Renewal fee patent year 03
10.04.2017Renewal fee patent year 04
09.04.2018Renewal fee patent year 05
08.04.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.04.2014
AL12.06.2019
AT12.06.2019
CY12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
ES12.06.2019
FI12.06.2019
HR12.06.2019
IT12.06.2019
LT12.06.2019
LV12.06.2019
MC12.06.2019
MK12.06.2019
MT12.06.2019
NL12.06.2019
PL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SI12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
[2022/32]
Former [2022/28]HU03.04.2014
AL12.06.2019
AT12.06.2019
CY12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
ES12.06.2019
FI12.06.2019
HR12.06.2019
IT12.06.2019
LT12.06.2019
LV12.06.2019
MC12.06.2019
MT12.06.2019
NL12.06.2019
PL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SI12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/52]AL12.06.2019
AT12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
ES12.06.2019
FI12.06.2019
HR12.06.2019
IT12.06.2019
LT12.06.2019
LV12.06.2019
MC12.06.2019
NL12.06.2019
PL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SI12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/36]AL12.06.2019
AT12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
ES12.06.2019
FI12.06.2019
HR12.06.2019
IT12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
PL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SI12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/24]AL12.06.2019
AT12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
ES12.06.2019
FI12.06.2019
HR12.06.2019
IT12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
PL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SI12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
PT14.10.2019
IS24.02.2020
Former [2020/22]AL12.06.2019
AT12.06.2019
CZ12.06.2019
DK12.06.2019
EE12.06.2019
ES12.06.2019
FI12.06.2019
HR12.06.2019
IT12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/17]AL12.06.2019
AT12.06.2019
CZ12.06.2019
EE12.06.2019
ES12.06.2019
FI12.06.2019
HR12.06.2019
IT12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SK12.06.2019
SM12.06.2019
TR12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/13]AL12.06.2019
AT12.06.2019
CZ12.06.2019
EE12.06.2019
ES12.06.2019
FI12.06.2019
HR12.06.2019
IT12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SK12.06.2019
SM12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/12]AL12.06.2019
AT12.06.2019
CZ12.06.2019
EE12.06.2019
ES12.06.2019
FI12.06.2019
HR12.06.2019
IT12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SK12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
IS12.10.2019
PT14.10.2019
Former [2020/11]AL12.06.2019
AT12.06.2019
CZ12.06.2019
EE12.06.2019
ES12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
SK12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
PT14.10.2019
Former [2020/10]AL12.06.2019
AT12.06.2019
CZ12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RO12.06.2019
RS12.06.2019
SE12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
PT14.10.2019
Former [2020/09]AL12.06.2019
CZ12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RS12.06.2019
SE12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
Former [2020/07]AL12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
NL12.06.2019
RS12.06.2019
SE12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
Former [2019/51]AL12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
RS12.06.2019
SE12.06.2019
BG12.09.2019
NO12.09.2019
GR13.09.2019
Former [2019/50]AL12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
LV12.06.2019
RS12.06.2019
SE12.06.2019
NO12.09.2019
GR13.09.2019
Former [2019/49]AL12.06.2019
FI12.06.2019
HR12.06.2019
LT12.06.2019
SE12.06.2019
NO12.09.2019
Former [2019/48]FI12.06.2019
LT12.06.2019
SE12.06.2019
NO12.09.2019
Former [2019/47]FI12.06.2019
LT12.06.2019
NO12.09.2019
Documents cited:Search[A]WO03071252  (EXACT SCIENCES CORP [US])[A] 1-15;
 [A]WO2012049279  (UNIV SAARLAND [DE], et al) [A] 1-15;
 [A]WO2012129352  (UNIV YALE [US], et al) [A] 1-15
International search[Y]US2010248252  (SHUBER ANTHONY P [US], et al) [Y] 1-3, 5-7, 10-12, 14, 15 * entire document *;
 [Y]US2011129832  (MAKAROV VLADIMIR [US], et al) [Y] 1-3, 5-7, 10-12, 14, 15 * entire document *;
 [Y]US2011158944  (HOSTED THOMAS J [US], et al) [Y] 1-3, 5-7, 10-12, 14 * entire document *;
 [Y]WO2012028746  (CENTRE NAT RECH SCIENT [FR], et al) [Y] 1-3, 5-7, 10-12, 14, 15 * entire document *;
 [TX]WO2014168801  (MERCK SHARP & DOHME [US], et al) [TX] 1-3, 5-7, 10-12, 14,15 * entire document *;
 [XP]  - CHANG et al., "Development and Validation of a Clinical Trial Patient Stratification Assay That Interrogates 27 Mutation Sites in.MAPK Pathway Genes", Plos One, (20130821), vol. 8, no. Iss. 8, XP055228566 [XP] 1-3, 5-7, 10-12, 14, 15 * . entire document *

DOI:   http://dx.doi.org/10.1371/journal.pone.0072239
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.